These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 21984132
1. Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas. Conti A, Pontoriero A, Arpa D, Siragusa C, Tomasello C, Romanelli P, Cardali S, Granata F, De Renzis C, Tomasello F. Acta Neurochir (Wien); 2012 Feb; 154(2):203-9. PubMed ID: 21984132 [Abstract] [Full Text] [Related]
2. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1066-74. PubMed ID: 20932651 [Abstract] [Full Text] [Related]
3. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):655-60. PubMed ID: 22483738 [Abstract] [Full Text] [Related]
4. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A. Anticancer Res; 2003 Nov 01; 23(6D):5159-64. PubMed ID: 14981983 [Abstract] [Full Text] [Related]
5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F. Neurosurg Focus; 2014 Dec 01; 37(6):E4. PubMed ID: 25434389 [Abstract] [Full Text] [Related]
6. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD. J Neurosurg; 2015 Apr 01; 122(4):757-65. PubMed ID: 25594327 [Abstract] [Full Text] [Related]
8. Outcome of salvage treatment for recurrent glioblastoma. Kim HR, Kim KH, Kong DS, Seol HJ, Nam DH, Lim DH, Lee JI. J Clin Neurosci; 2015 Mar 01; 22(3):468-73. PubMed ID: 25595963 [Abstract] [Full Text] [Related]
9. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P. J Clin Oncol; 2005 Apr 01; 23(10):2372-7. PubMed ID: 15800329 [Abstract] [Full Text] [Related]
10. Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. Scoccianti S, Detti B, Sardaro A, Iannalfi A, Meattini I, Leonulli BG, Borghesi S, Martinelli F, Bordi L, Ammannati F, Biti G. Anticancer Drugs; 2008 Jul 01; 19(6):613-20. PubMed ID: 18525321 [Abstract] [Full Text] [Related]
12. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. Chamberlain MC, Tsao-Wei DD. Cancer; 2004 Mar 15; 100(6):1213-20. PubMed ID: 15022289 [Abstract] [Full Text] [Related]
13. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, Weiss C, Rödel C. Radiother Oncol; 2010 Dec 15; 97(3):382-6. PubMed ID: 20850883 [Abstract] [Full Text] [Related]
14. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):473-8. PubMed ID: 18554821 [Abstract] [Full Text] [Related]
15. Continuous tamoxifen and dose-dense temozolomide in recurrent glioblastoma. DI Cristofori A, Carrabba G, Lanfranchi G, Menghetti C, Rampini P, Caroli M. Anticancer Res; 2013 Aug 01; 33(8):3383-9. PubMed ID: 23898108 [Abstract] [Full Text] [Related]
16. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma. Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, Hashimoto K, Uemae Y, Ishihara T, Matsuda M, Matsutani M, Karasawa K, Nakazato Y, Abe T, Ohno T, Matsumura A. J Neurosurg; 2014 Sep 01; 121(3):543-53. PubMed ID: 24995786 [Abstract] [Full Text] [Related]
18. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Cancer; 2005 Nov 15; 104(10):2168-73. PubMed ID: 16220556 [Abstract] [Full Text] [Related]
19. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Kocher M, Frommolt P, Borberg SK, Rühl U, Steingräber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H, Müller RP. Strahlenther Onkol; 2008 Nov 15; 184(11):572-9. PubMed ID: 19016015 [Abstract] [Full Text] [Related]